Alice I. Kim, MD, MBA, at ID Care

Alice Kim, Infectious Disease Doctor

Infectious Disease Physician Expertise

  • Board certified in infectious disease by the American Board of Internal Medicine (ABIM)
  • Specializing in the treatment of all infectious diseases

Education

  • Master of Business Administration: Case Western Reserve University (2021)
  • Fellowship: The Cleveland Clinic Foundation (2003)
  • Residency: The Cleveland Clinic Foundation (2001)
  • Medical School: Northeast Ohio Medical University (1997)
  • Undergraduate: University of Akron (1993)

Why I’m an infectious disease specialist

“I specialize in infectious diseases because of my dedication to patient care and public health. With extensive experience in clinical and administrative roles, I’m committed to advancing healthcare systems, national advocacy efforts, and making a meaningful impact in infectious disease management and prevention.”

Approach to infectious disease care

President & CEO Dr. Alice Kim’s approach to infectious disease care centers on making a meaningful impact in infectious disease management and prevention that focuses on quality patient care and enhancing public health initiatives. With extensive leadership and administrative experience, she emphasizes clinical excellence and operational efficiency. As ID Care’s leader, she focuses on recruiting top talent, aiming to elevate the practice through talent recruitment, strategic partnerships and promoting innovative care delivery models. Dr. Kim’s clinical interests and advocacy efforts further enhance her impact in advancing infectious disease care standards.

More about Alice Kim, infectious disease doctor

Dr. Alice Kim, MD, MBA, is the president and CEO of ID Care, New Jersey’s premier infectious disease group. With 26 years of experience, including clinical and administrative positions at the Cleveland Clinic, and a passion for quality care and innovation, she’s known for her clinical and administrative expertise and leadership. She led standardization and improvement of post acute care services, hospital throughput, and value-based care initiatives, improving overall operational efficiency. During COVID-19, Dr. Kim coordinated state and regional responses, earning recognition from the Cleveland Clinic and the State of Ohio. Her interests include cardiac device infections and endocarditis.

Leadership
  • Cleveland Clinic Medical Director, Enterprise Medical and Regional Operations
  • Cleveland Clinic, Clinical Operation Lead Construction and Operations Planning for Mentor Hospital Build, 2021-2023
  • Medical Director, Cleveland Clinic and Select Medical Joint Venture, 2016-2023
  • Cleveland Clinic, Medical Director of Inpatient Care Coordination, 2019-2023
  • Cleveland Clinic Enterprise Operational Lead, 2020 – 2023, Pandemic and Public Health Emergency Response
  • Deputy Commander and Clinical Leader, March 2020 – 2022, State of Ohio, COVID-19 Zone 1
  • Incident Command Co-Leader, March 2020 – 2021, Cleveland Clinic COVID-19 Pandemic Response
  • Operational Lead, Jan – Feb 2022. Dept. of Defense, Airforce, Medical Staff Deployment at Cleveland Clinic
  • Co-Medical Director, March – June 2021, FEMA COVID-19 Mass Vaccination Site at Wolstein Center, Cleveland, Ohio
Memberships
  • Cleveland Clinic Alumni Board of Directors, 2017-present, Vice President of Membership, 2022-present
  • Infectious Diseases Society of America (IDSA): Chair, Clinical Affairs Committee, 2021-2023. Advocacy Captain, 2023-present
  • IDSA: Leadership Institute Selection Task Force Committee Member, 2018, 2019
  • IDSA Pandemic Preparedness Advisory Group, 2023-24
  • IDSA Fellowship Taskforce, 2023
  • Beta Gamma Sigma: International Business Honor Society, member, 2021-present
Research
  • Monoclonal antibodies for treating COVID-19. Cleveland Clinic Journal of Medicine February 2021
  • Addressing COVID-19 health disparities through a regional community health response. Posted February 10, 2021. Cleveland Clinic Journal of Medicine February 2021
  • Post Acute to Home (P.A.T.H) Project. Partner with HVTI and Care management. August 2020-ongoing
  • Home monitoring for COVID-19. Cleveland Clinic Journal of Medicine June 2020
  • Quality Measure Concepts for Practice Guideline Adherence and Optimization in Patients with Staphylococcus aureus Bacteremia over a Seven-Year Period in a Health Care System
  • Analytics-Driven Patient Care Bundle to drive Enhanced Recovery After Cardiothoracic Surgery
  • Infectious Diseases Society of America Physician Compensation Survey: Results and Analysis. Open Forum Infectious Diseases, Vol 5, Issue 12
  • Cardiac implantable electronic device infections: added complexity and suboptimal outcomes with previously abandoned leads. JACC: Clinical Electrophysiology
  • Implications of central venous catheters in patients with stage D Heart failure who are stable but inotrope dependent. J Card Fail
  • Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm
  • Complications and Intensity of Care of Community-Based Parenteral Anti-Infective Therapy for Patients with Cardiac Infections. Poster Presentation. IDSA Annual Meeting
  • Outcomes in Patients Following Surgery for Infective Endocarditis: The Contemporary Cleveland Clinic Experience. Poster Presentation. IDSA Annual Meeting
  • “Mycoses.” In Cleveland Clinic Current Clinical Medicine
  • Infectious endocarditis prophylaxis before dental procedures: new Guidelines spark controversy. Cleve Clin J Med.
  • The ultimate development of mitral valve endocarditis: atrioventricular separation, atrioventricular groove abscess and hemorrhagic pericarditis. J Heart Valve Dis.
  • Detection of coagulase-negative staphylococcus Hickman catheter infections by Real-time PCR of whole blood using Light Cycler Staphylococcus M Grade Kits: A pilot Project. Poster presentation at the American Society for Microbiology 105th General Meeting
  • The use of molecular methods to determine the Cause of mycobacterial infections. Pathology Case Reviews
  • Using Echocardiography to guide length of therapy. The Cleveland Clinic Journal of Medicine
  • Diabetic neuropathic (Charcot) arthropathy: A forgotten Diagnosis? Poster presentation at the Society of General Internal Medicine Annual Meeting
  • Diagnostic utility and cost effectiveness of neuroimaging, EEG, and Laboratory investigations in the evaluation of children admitted to a psychiatric unit. Poster presentation at the American Academy of Pediatrics Annual Meeting

Awards
  • Cleveland Clinic Enterprise Pharmacy Distinguished Partner Award Recipient, 2022
  • Cleveland Clinic Caregiver Team Award Winner-Enterprise Monoclonal Antibody Team, 2022
  • Cleveland Clinic Caregiver Team Award Winner-Euclid SNF 2021
  • Cleveland Clinic COVID-Hero Individual Award Recipient 2020
  • State of Ohio:
    • The Ohio Commendation Medal from Ohio Governor and Major General John C Harris, for outstanding service as Medical Director supporting Task Force Magnus at FEMA COVID Mass Vaccination site at Cleveland State University Wolstein Center, June 3, 2021
    • Certificate of Appreciation from Brigadier General Rebecca O’Connor and Ohio Emergency Management Executive Director Sima Merick for support of Ohio’s largest COVID mass vaccination facility, June 7, 2021